Oncology and therapy
Investigating Real-World Evidence and Reported Survival Outcomes of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer.
Sarah Sammons, Denise A Yardley, Priyanka Sharma, Vijayakrishna K Gadi, Mark Pegram, Purnima Pathak, Huilin Hu, Gary Sopher, Peter A Fasching
Published: 202510.1007/s40487-025-00394-8
No abstract available for this study.